do glp 1 cause bone density issues GLP-1s and Health: What the Evidence Says About Semaglutide, Bone Density, and Muscle Loss GLP-1 and GIP: Magic bullet

, ,

In the A Study of Tirzepatide [LY3298176] in Participants with Type 2 Diabetes (SURPASS-2) trial, tirzepatide (5 to 15 mg) was superior to 1.0 mg of semaglutide in improving both HbA1c and body weight [5], in contrast to our results

BPC-157 is a carefully synthesized pentadecapeptide with specific molecular characteristics that defines its research applications

Direct stem cell therapy means injecting stem cells into your body

Horiuchi Y, Wettersten N, Asami M, Yahagi K, Komiyama K, Yuzawa H, Tanaka J, Aoki J, Tanabe K (2025) Glucagon-like peptide-1 receptor agonists improve outcomes in individuals with type 2 diabetes with and without heart failure

By engaging patients in shared decision-making, clinicians can select the most appropriate starting point and improve long-term outcomes